BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2963736)

  • 21. [Clinical and experimental study of shenshao tongguan pian in treating angina pectoris of coronary heart disease].
    Hu JX; Jia GX; Yan ZR
    Zhong Xi Yi Jie He Za Zhi; 1990 Oct; 10(10):596-9, 580. PubMed ID: 2268917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thromboxane and prostacyclin in patients with stenocardia in induced and spontaneous ischemia of the myocardium].
    Panchenko EP; Smirnov IE; Ziabkina AG; Ianus VM; Kocherga EIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):73-9. PubMed ID: 3754753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on platelets and coagulofibrinolytic system in ischemic heart disease].
    Kuroiwa Y
    Igaku Kenkyu; 1988 Dec; 58(6):383-95. PubMed ID: 2978105
    [No Abstract]   [Full Text] [Related]  

  • 24. Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome.
    Grande P; Grauholt AM; Madsen JK
    Circulation; 1990 Jan; 81(1 Suppl):I16-9; discussion I22-3. PubMed ID: 2136815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of medical therapy on long-term survival in ischemic heart disease].
    Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT
    Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of qixue injections on the function of platelets in coronary disease patients].
    Wang SR; Liao JZ
    Zhong Xi Yi Jie He Za Zhi; 1987 Jan; 7(1):12-4, 3. PubMed ID: 3594704
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet activity in acute and chronic ischemic heart disease, with reference to the type of hyperlipoproteinemia.
    Stăncioiu N; Scrobohaci ML; Zătreanu I; Orha I
    Med Interne; 1978; 16(4):395-403. PubMed ID: 749178
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered sensitivity to prostacyclin may be involved in the exercise-induced activation of platelets in patients with ischemic heart disease.
    Kishi Y; Numano F; Oniki T; Yajima M; Numano F
    Prog Clin Biol Res; 1989; 301():181-5. PubMed ID: 2508101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of sheng-mai decoction on left ventricular performance and exercise tolerance in patients with dilated cardiomyopathy].
    Jiang J; Fang J; Luo DC
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):65-7, 125. PubMed ID: 3058445
    [No Abstract]   [Full Text] [Related]  

  • 31. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations made with Sensit in the treatment of angina pectoris patients.
    Keller L; Landi A
    Ther Hung; 1983; 31(4):176-80. PubMed ID: 6400457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias].
    Barbato G; Klein H; Lichtlen PR
    Z Kardiol; 1989; 78 Suppl 5():98-102. PubMed ID: 2698571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical research on shengjie tongyu granules in the treatment of meteorological cardiovascular disease.
    Zhai G; Dong J; Wang S; Shang K
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):785-9. PubMed ID: 25796155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
    Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
    Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of sheng mai san on left ventricular performance in coronary heart disease.
    Liao JZ; Wu ZM; Kang TP; Shi ZX; Guo LZ; Zhao YR; Wang ZG; Hao QC
    J Tradit Chin Med; 1982 Mar; 2(1):57-62. PubMed ID: 6765690
    [No Abstract]   [Full Text] [Related]  

  • 38. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
    Hirsh PD; Hillis LD; Campbell WB; Firth BG; Willerson JT
    N Engl J Med; 1981 Mar; 304(12):685-91. PubMed ID: 6894016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet aggregation, coronary artery disease progression and future coronary events.
    Lam JY; Latour JG; Lespérance J; Waters D
    Am J Cardiol; 1994 Feb; 73(5):333-8. PubMed ID: 8109546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T; Samama M
    Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.